Neurologic - Novartis

A Randomized, Double-blind, Double-dummy, Parallel-group Study, Comparing the Efficacy and Safety of Remibrutinib Versus Teriflunomide in Participants With Relapsing Multiple Sclerosis, Followed by Extended Treatment With Open-label Remibrutinib

Phase

Phase III

Condition

Relapsing Forms of Multiple Sclerosis, RMS, MS

Keywords

Relapsing Forms of Multiple Sclerosis | RMS | MS